Carmen C Sucharov1, Juliana Sucharov2, Anis Karimpour-Fard3, Karin Nunley4, Brian L Stauffer5, Shelley D Miyamoto6. 1. Division of Cardiology, Denver Department of Medicine, University of Colorado, Aurora, Colorado. Electronic address: kika.sucharov@ucdenver.edu. 2. Pediatric Research Program, Children's Hospital Colorado. 3. Center for Computational Pharmacology, University of Colorado School of Medicine, Aurora, Colorado. 4. Division of Cardiology, Denver Department of Medicine, University of Colorado, Aurora, Colorado. 5. Division of Cardiology, Denver Department of Medicine, University of Colorado, Aurora, Colorado; Division of Cardiology, Denver Health and Hospital Authority, Denver, Colorado. 6. Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, Colorado. Electronic address: shelley.miyamoto@childrenscolorado.org.
Abstract
OBJECTIVE: Micro-RNAs (miRNAs) are important regulators of gene expression through interaction with the 3'UTR of target messenger RNAs (mRNAs). The role of miRNAs has been extensively studied in adult human and nonhuman animal models of heart disease. Hypoplastic left heart syndrome (HLHS) is the most common form of severe congenital heart disease and is an important cause of morbidity and mortality in infants and children. The objective of this work was to analyze the miRNA profile in HLHS patients. METHODS AND RESULTS: miRNA profile was determined in the right ventricle with the use of miRNA array, and expression was validated with the use of reverse-transcription polymerase chain reaction (RT-PCR). Based on bioinformatics analysis, targets were selected and their expression analyzed with the use of RT-PCR.We found that the miRNA profile of HLHS is novel, with few similarities between pediatric and adult idiopathic dilated cardiomyopathy. Moreover, our analysis identified putative targets for these miRNAs that are known to be important for cardiac development and disease, and that miRNAs and their putative targets are antithetically regulated. We also found that miRNA expression changes with stage of surgery, suggesting that volume unloading of the ventricle has important consequences for gene expression. CONCLUSIONS: Our data suggest a unique miRNA profile for HLHS that may be associated with defects in cardiac development and disease.
OBJECTIVE: Micro-RNAs (miRNAs) are important regulators of gene expression through interaction with the 3'UTR of target messenger RNAs (mRNAs). The role of miRNAs has been extensively studied in adult human and nonhuman animal models of heart disease. Hypoplastic left heart syndrome (HLHS) is the most common form of severe congenital heart disease and is an important cause of morbidity and mortality in infants and children. The objective of this work was to analyze the miRNA profile in HLHSpatients. METHODS AND RESULTS: miRNA profile was determined in the right ventricle with the use of miRNA array, and expression was validated with the use of reverse-transcription polymerase chain reaction (RT-PCR). Based on bioinformatics analysis, targets were selected and their expression analyzed with the use of RT-PCR.We found that the miRNA profile of HLHS is novel, with few similarities between pediatric and adult idiopathic dilated cardiomyopathy. Moreover, our analysis identified putative targets for these miRNAs that are known to be important for cardiac development and disease, and that miRNAs and their putative targets are antithetically regulated. We also found that miRNA expression changes with stage of surgery, suggesting that volume unloading of the ventricle has important consequences for gene expression. CONCLUSIONS: Our data suggest a unique miRNA profile for HLHS that may be associated with defects in cardiac development and disease.
Authors: Shelley D Miyamoto; Brian L Stauffer; Jeremy Polk; Allen Medway; Matthew Friedrich; Kurt Haubold; Valencia Peterson; Karin Nunley; Penny Nelson; Rebecca Sobus; Kurt R Stenmark; Carmen C Sucharov Journal: J Heart Lung Transplant Date: 2014-03-05 Impact factor: 10.247
Authors: Elisabeth Sock; Stefanie D Rettig; Janna Enderich; Michael R Bösl; Ernst R Tamm; Michael Wegner Journal: Mol Cell Biol Date: 2004-08 Impact factor: 4.272
Authors: Rosanne Rouf; Sarah Greytak; Eric C Wooten; Jing Wu; Jay Boltax; Michael Picard; Eric C Svensson; Wolfgang H Dillmann; Richard D Patten; Gordon S Huggins Journal: Circ Res Date: 2008-07-25 Impact factor: 17.367
Authors: Sarah C Hoelscher; Stefanie A Doppler; Martina Dreßen; Harald Lahm; Rüdiger Lange; Markus Krane Journal: J Thorac Dis Date: 2017-03 Impact factor: 2.895
Authors: Carmen C Sucharov; David P Kao; J David Port; Anis Karimpour-Fard; Robert A Quaife; Wayne Minobe; Karin Nunley; Brian D Lowes; Edward M Gilbert; Michael R Bristow Journal: JCI Insight Date: 2017-01-26
Authors: Anastacia M Garcia; Jessica C McPhaul; Genevieve C Sparagna; Danielle A Jeffrey; Raleigh Jonscher; Sonali S Patel; Carmen C Sucharov; Brian L Stauffer; Shelley D Miyamoto; Kathryn C Chatfield Journal: Am J Physiol Heart Circ Physiol Date: 2020-02-14 Impact factor: 4.733
Authors: Stephanie J Nakano; Austine K Siomos; Anastacia M Garcia; Hieu Nguyen; Megan SooHoo; Csaba Galambos; Karin Nunley; Brian L Stauffer; Carmen C Sucharov; Shelley D Miyamoto Journal: J Pediatr Date: 2017-10-16 Impact factor: 4.406
Authors: Emily C Willner; Henry L Galan; Bettina F Cuneo; Hilary A Hoffman; Bonnie Neltner; Eleanor L Schuchardt; Anis Karimpour-Fard; Shelley D Miyamoto; Carmen C Sucharov Journal: Am J Obstet Gynecol Date: 2021-06-19 Impact factor: 10.693
Authors: Jack Rubinstein; Jessica G Woo; Anastacia M Garcia; Tarek Alsaied; Jia Li; Per Kristian Lunde; Ryan A Moore; Martin Laasmaa; Amanda Sammons; Wayne A Mays; Shelley D Miyamoto; William E Louch; Gruschen R Veldtman Journal: Pediatr Cardiol Date: 2020-08-07 Impact factor: 1.655